Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;27(8):4567-4570.
doi: 10.1111/dom.16436. Epub 2025 May 5.

Omnipod 5 in children and adolescents with type 1 diabetes: Improved outcomes with fewer boluses

Davide Tinti  1 , Valeria Castorani  2 , Cecilia Nobili  1 , Barbara Felappi  3 , Elena Prandi  3 , Barbara Piccini  4 , Sonia Toni  4 , Marta Bassi  5 , Nicola Minuto  5 , Riccardo Bonfanti  6 , Francesca Di Candia  7 , Enza Mozzillo  7 , Marco Marigliano  8 , Claudio Maffeis  8 , Andrea Enzo Scaramuzza  9 , Ivana Rabbone  2
Affiliations

Omnipod 5 in children and adolescents with type 1 diabetes: Improved outcomes with fewer boluses

Davide Tinti et al. Diabetes Obes Metab. 2025 Aug.
No abstract available

Keywords: CSII; continuous glucose monitoring; glycaemic control; insulin pump therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

FIGURE 1
FIGURE 1
TIR (A) and TITR (B) values from baseline to week 4. Values are shown as boxplots. *p < 0.05 with repeated measures ANOVA.
See this image and copyright information in PMC

References

    1. Brown SA, Kovatchev BP, Raghinaru D, et al. Six‐month randomized, multicenter trial of closed‐loop control in type 1 diabetes. N Engl J Med. 2019;381(18):1707‐1717. - PMC - PubMed
    1. Tauschmann M, Thabit H, Bally L, et al. Closed‐loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12‐week randomised trial. Lancet. 2018;392(10155):1321‐1329. - PMC - PubMed
    1. Bergenstal RM, Garg S, Weinzimer SA, et al. Safety of a hybrid closed‐loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316(13):1407‐1408. - PubMed
    1. Leelarathna L, Choudhary P, Wilmot EG, et al. Hybrid closed‐loop therapy: where are we in 2021? Diabetes Obes Metab. 2021;23(3):655‐660. - PubMed
    1. Nir J, Rachmiel M, Fraser A, et al. Open‐source automated insulin delivery systems (OS‐AIDs) in a pediatric population with type 1 diabetes in a real‐life setting: the AWeSoMe study group experience. Endocrine. 2023;81(2):262‐269. - PubMed

LinkOut - more resources